A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial

European Journal of Cancer

Volumn 96, Issue , 2018, Pages 54-63

  Matsuda, Chu ^a   Ishiguro, Megumi ^b   Teramukai, Satoshi ^c   Kajiwara, Yoshiki ^d   Fujii, Shoichi ^e   Kinugasa, Yusuke ^f   Nakamoto, Yoshihiko ^g   Kotake, Masanori ^h   Sakamoto, Yoshiyuki ⁱ   Kurachi, Kiyotaka ^j   Maeda, Atsuyuki ^k   Komori, Koji ^l   Tomita, Naohiro ^m   Shimada, Yasuhiro ⁿ   Takahashi, Keiichi ^o   Kotake, Kenjiro ^p   Watanabe, Masahiko ^q   Mochizuki, Hidetaka ^d   Nakagawa, Yoko ^r   Sugihara, Kenichi ^b  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^e YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^f SHIZUOKA CANCER CENTER   (Japan)

^g KOBE CITY MEDICAL CENTER WEST HOSPITAL   (Japan)

^h KOUSEIREN TAKAOKA HOSPITAL   (Japan)

ⁱ HIROSAKI UNIVERSITY   (Japan)

^j HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k OGAKI MUNICIPAL HOSPITAL   (Japan)

^l AICHI CANCER CENTER HOSPITAL   (Japan)

^m HYOGO COLLEGE OF MEDICINE   (Japan)

ⁿ Kochi Health Sciences Center   (Japan)

^o TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^p TOCHIGI CANCER CENTER   (Japan)

^q KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

more..

Author keywords

Adjuvant chemotherapy; Colon cancer; Stage II; Tegafur uracil (UFT)

Indexed keywords

ANTINEOPLASTIC AGENT; TEGAFUR; URACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; CANCER STAGING; CLINICAL TRIAL; COLON RESECTION; COLON TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; JAPAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; TEGAFUR; TIME FACTORS; TREATMENT OUTCOME; URACIL;

EID: 85045703764     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2018.03.009     Document Type: Article

References (18)

1. Center for Cancer Control and Information Services, National Cancer Center. Projected cancer statistics, 2017. http://ganjoho.jp/en/public/statistics/short_pred.html; 2017 [Accessed 5 December 2017].
2. Kannarkatt, J., Joseph, J., Kurniali, P.C., et al. Adjuvant chemotherapy for stage II colon cancer: a clinical dilemma. J Oncol Pract 13 (2017), 233–241.
3. Mamounas, E., Wieand, S., Wolmark, N., et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17 (1999), 1349–1355.
4. Sakamoto, J., Ohashi, Y., Hamada, C., et al. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. J Clin Oncol 22 (2004), 484–492.
5. Schrag, D., Rifas-Shiman, S., Saltz, L., et al. Adjuvant chemotherapy use for medicare beneficiaries with stage II colon cancer. J Clin Oncol 20 (2002), 3999–4005.
6. Sato, H., Maeda, K., Sugihara, K., et al. High-risk stage II colon cancer after curative resection. J Surg Oncol 104 (2011), 45–52.
7. Hoshino, N., Hasegawa, S., Hida, K., et al. Nomogram for predicting recurrence in stage II colorectal cancer. Acta Oncol 55 (2016), 1414–1417.
8. Shi, Q., Andre, T., Grothey, A., et al. Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database. J Clin Oncol 31 (2013), 3656–3663.
9. National Comprehensive Cancer Network. Clinical practice guidelines in Oncology; colon cancer version 2. 2017. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf; 2017 [Accessed 5 December 2017].
10. Benson, A.B. III, Schrag, D., Somerfield, M.R., et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22 (2004), 3408–3419.
11. Labianca, R., Nordlinger, B., Beretta, G.D., et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 24, 2013 vi64–72.
12. Hamaguchi, T., Shirao, K., Moriya, Y., et al. Final results of randomized trials by the National Surgical adjuvant study of colorectal cancer (NSAS-CC). Cancer Chemother Pharmacol 67 (2011), 587–596.
13. Kato, T., Ohashi, Y., Nakazato, H., et al. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial. Langenbeck's Arch Surg 386 (2002), 575–581.
14. Ishiguro, M., Mochizuki, H., Tomita, N., et al. Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer. BMC Cancer, 12, 2012, 281.
15. Watanabe, M., Nishida, O., Kunii, Y., et al. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur. Int J Clin Oncol 9 (2004), 98–106.
16. Schoenfeld, D.A., Richter, J.R., Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 38 (1982), 163–170.
17. Japanese Society of Cancer of the Colon and Rectum: Japanese classification of colorectal carcinoma, second English edition, 2009, Kanehara & Co, Tokyo, Japan.
18. Tournigand, C., André T., Bonnetain, F., et al. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol 30 (2012), 3353–3360.